Latest News and Press Releases

– Phase 3 programs underway for DURAVYU in wet AMD and DME, the largest multi-billion-dollar retinal disease markets – – Pivotal Phase 3 trials in wet AMD on track for data readout beginning in...

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Bora...

Frontier Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference

PHOENIX, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Jacob Tilzer, in partnership with Accrual Equity Partners, announced today the launch of Gemba Automotive, a technology enabled automotive services...

FORESIGHT VENTURES VCT PLCLEI: 213800R88MRC4Y3OIW86SPECIAL DIVIDEND DECLARATION7 JANUARY 2026 Following the successful part realisation of Ayar Labs Inc, the Board of Foresight Ventures VCT plc is...

Favorable safety, tolerability, pharmacokinetic and pharmacodynamic profiles validate and significantly de-risk the programSupports the feasibility of intravenous and subcutaneous dosing regimens in...

Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "CSA in Practice: How to Build Defensible Evidence the FDA Actually Wants to See (Jan 13, 2026)" training has been added to ResearchAndMarkets.com's...

Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "How to Validate Automated Pipelines Under CSA (Jan 23, 2026)" training has been added to ResearchAndMarkets.com's offering.This 3-Hour course teaches...

Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "IQ, OQ, PQ in the Verification and Validation Process (Jan 28, 2026)" training has been added to ResearchAndMarkets.com's offering.This course will...

YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs